Viewing Study NCT01430260


Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2025-12-30 @ 9:29 AM
Study NCT ID: NCT01430260
Status: COMPLETED
Last Update Posted: 2012-09-06
First Post: 2011-09-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Omnaris Versus Levocetirizine Phase 4 Study
Sponsor: Handok Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: HANDOK2010.07
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View